関連する実験動画
Updated: Sep 10, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.2K
組織性硬化症におけるHAQ-DIスコアで測定された身体機能の悪化の臨床関連
Jessica L Fairley1,2,3, Dylan Hansen2, Susanna Proudman4,5
1The University of Melbourne, Melbourne, VIC, Australia.
Journal of scleroderma and related disorders
|August 25, 2025
まとめ
全身性硬化症患者の3分の2が機能的変化を経験した. 症状の悪化とC反応性タンパク質 (CRP) の上昇は身体機能に重大な影響を及ぼし,介入の重要な領域を強調しました.
科学分野:
- リウマトロジ
- 臨床医学
- 患者 の 結果
背景:
- 機能障害による全身性硬化症 (SSc) は,日常生活に大きな影響を及ぼします.
- 健康評価アンケート-障害指数 (HAQ-DI) は,SSc患者における機能状態の重要な指標である.
- HAQ-DIの変化を理解することは,SScの管理に不可欠です.
研究 の 目的:
- SScコホート内のHAQ-DIスコアにおける臨床的に有意義な変化の頻度を決定する.
- HAQ-DIスコアの悪化または改善に関連する臨床的要因を特定する.
- 事件性および拡散性SScを含むサブグループでこれらの関連を分析する.
主な方法:
- オーストラリア・スクレロダーマ・コホート・スタディのデータを活用した.
- 2回の訪問の時間枠内で記録されたHAQ-DIスコアを少なくとも2つ獲得した参加者を含む.
- HAQ-DIにおける臨床的に重要な最小差 (MCID) に関するモデル因子に対する概括的な推定方程式を使用した.
主要な成果:
- 参加者の64%はHAQ-DIスコアが悪化し,ベースラインスコア >=0. 125ユニットの71%は改善した.
- HAQ-DIの悪化に関連した要因には,高齢化,皮膚スコアの上昇,指の潰瘍,C反応性タンパク質 (CRP) の上昇,および患者の報告したレイノ現象と呼吸不全の悪化が含まれる.
- ベースラインより高いHAQ-DIスコアは,全体的なコホートにおける改善と関連した唯一の要因でした.
結論:
- 大半のSScコホートでは,機能的変化が著しく悪化したり改善したりした.
- CRPの上昇と症状の増加は,SScの機能的低下を決定する重要な要因です.
- これらの発見は,SScにおける身体機能管理のための炎症マーカーと症状のモニタリングの重要性を強調しています.
関連する概念動画
Rheumatic Heart Disease I: Introduction
39
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
39
Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87
Rheumatic Heart Disease IV: Nursing Management
37
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
37
Heart Failure III: Clinical Manifestations
43
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
43
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
Assessment of the Cardiovascular System III: Palpation
492
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
492

